Trade Summary

2 days ago, Quinlan Paul T, serving as GC at Oruka Therapeutics, Inc. (ORKA), sold 733 shares at $41.30 per share, for a total transaction value of $30,273.00. Following this transaction, Quinlan Paul T now holds 31,767 shares of ORKA.

This sale represents a 2.00% decrease in Quinlan Paul T's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 17, 2026, 1 day after the trade was made.

Oruka Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.